| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.0075 | 0.9 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |